人工智能在局灶性肝脏病变检测与表征中的应用:综述
本综述检索2010年1月至2024年4月的文献,纳入45项研究,评估人工智能算法在CT和MRI上检测和表征局灶性肝脏病变的诊断能力。多数系统采用卷积神经网络,以专家放射科医生手动勾画病灶为参考标准、组织学为金标准。综述指出AI算法在检测和表征局灶性肝脏病变方面表现出高准确率、敏感度、特异度和AUC,在区分良恶性病变、优化诊断流程和减少侵入性操作需求方面表现突出。未来研究应关注数据集扩展、模型可解释性提升及跨临床环境的验证。
要点
- AI算法在CT和MRI上检测和表征局灶性肝脏病变表现出高准确率、敏感度、特异度和AUC。
- 多数AI系统采用卷积神经网络,参考标准为专家放射科医生手动勾画病灶,金标准为组织学。
- AI在区分良性与恶性病变、优化诊断流程及减少侵入性操作需求方面表现突出。
核心结论
- 综述纳入的研究表明,基于AI的算法在检测和表征局灶性肝脏病变方面表现出高准确率、敏感度、特异度和AUC。
- 这些算法在区分良性与恶性病变、优化诊断流程和减少侵入性操作需求方面表现突出。
- 未来研究应集中于数据集扩展、模型可解释性提升以及AI工具在多种临床环境中的验证,以确保其适用性和可靠性。
研究设计与样本
- 本文为综述,检索2010年1月至2024年4月的文献,纳入45项相关研究。
- 多数AI系统采用卷积神经网络(CNN),由专家放射科医生通过手动勾画病灶提供参考标准,并以组织学为金标准。
诊断标准与关键数值
- 综述纳入的研究表明,基于AI的算法在检测和表征局灶性肝脏病变方面表现出高准确率、敏感度、特异度和AUC。
临床应用与阅片要点
- AI算法可用于检测和表征CT与MRI上的局灶性肝脏病变,重点在于区分良性病变与癌前病变及潜在恶性病变。
- AI算法在区分良恶性病变、优化诊断流程和减少侵入性操作需求方面表现突出。
局限性
- 未来研究应集中于数据集扩展、模型可解释性提升以及AI工具在多种临床环境中的验证,以确保其适用性和可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Focal liver lesions (FLL) are common incidental findings in abdominal imaging. While the majority of FLLs are benign and asymptomatic, some can be malignant or pre-malignant, and need accurate detection and classification. Current imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), play a crucial role in assessing these lesions. Artificial intelligence (AI), particularly deep learning (DL), offers potential solutions by analyzing large data to identify patterns and extract clinical features that aid in the early detection and classification of FLLs. This manuscript reviews the diagnostic capacity of AI-based algorithms in processing CT and MRIs to detect benign and malignant FLLs, with an emphasis in the characterization and classification of these lesions and focusing on differentiating benign from pre-malignant and potentially malignant lesions. A comprehensive literature search from January 2010 to April 2024 identified 45 relevant studies. The majority of AI systems employed convolutional neural networks (CNNs), with expert radiologists providing reference standards through manual lesion delineation, and histology as the gold standard. The studies reviewed indicate that AI-based algorithms demonstrate high accuracy, sensitivity, specificity, and AUCs in detecting and characterizing FLLs. These algorithms excel in differentiating between benign and malignant lesions, optimizing diagnostic protocols, and reducing the needs of invasive procedures. Future research should concentrate on the expansion of data sets, the improvement of model explainability, and the validation of AI tools across a range of clinical setting to ensure the applicability and reliability of such tools.
引用
- Arribas Anta J, Moreno-Vedia J, García López J, et al. Artificial intelligence for detection and characterization of focal hepatic lesions: a review. Abdom Radiol (NY). 2024. PMID: 39369107. doi:10.1007/s00261-024-04597-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。